Regulation And Legal
Mediclone Biotech NCLAT Hearing Adjourned to September 2
NCLAT Chennai adjourns Mediclone Biotech insolvency appeal hearing to September 2, 2026.
Interim order in favor of suspended director appellant continues until next hearing date.
Biotechnology Industr
